Introduction





Products Description
## 1. Classification and overview of peptide compounds
BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4) are two types of synthetic peptides with significant biological activity, which are widely used in medical research, sports rehabilitation and regenerative medicine. According to their structure, function and mechanism of action, they can be divided into the following categories:
### 1. Structural classification
- **Linear peptide (BPC-157)**:
A straight-chain polypeptide composed of 15 amino acid residues (molecular formula: C₆₂H₉₈N₁₆O₂₂, molecular weight: 1419.5 Da), with a sequence of Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.
- **Cyclic active peptide (TB-500)**:
A synthetic derivative of thymosin β4, containing 43 amino acids (molecular formula: C₂₁₂H₃₄₀N₅₄O₅₅S, molecular weight: 4963.1 Da), its core active region (Ac-Ser-Asp-Lys-Pro-Asp) forms a functional conformation through a β-turn structure.
### 2. Functional classification
- **Tissue repair (BPC-157)**: Targeting gastrointestinal mucosal repair, angiogenesis and tendon healing.
- **Cell migration regulation (TB-500)**: Promoting cell migration and wound repair by regulating actin polymerization.
## 2. Analysis of physical and chemical properties
### 1. Basic physical and chemical parameters
| Parameters | BPC-157 (5mg) | TB-500 (5mg) |
|---------------|---------------------------|----------------------------|
| **Appearance** | White to off-white freeze-dried powder | White crystalline powder |
| **Solubility** | Easily soluble in acidic aqueous solution (pH<5) | Need to be soluble in weak alkaline buffer (pH7-8) |
| **Stability** | Activity retention >95% after 3 years of storage at -20℃ | Stable for 2 years at 2-8℃ in freeze-dried state |
| **Isoelectric point (pI)** | 4.8±0.2 | 5.1±0.3 |
| **Hygroscopicity** | Low (water absorption <1% when RH<30%) | Medium (need to be stored in desiccant) |
### 2. Spectral characteristics
- **BPC-157**: UV absorption peak is located at 278nm (tyrosine residue), and infrared spectrum shows typical α-helix characteristics at 1650cm⁻¹ (amide I band) and 1540cm⁻¹ (amide II band).
- **TB-500**: Circular dichroism spectrum (CD) shows β-folding characteristic peaks at 208nm and 222nm, and nuclear magnetic resonance (NMR) shows dynamic conformational changes in its core tetrapeptide region.
## 3. Comparison of biological activity advantages
### 1. Core advantages of BPC-157
- **Multi-target repair**: By activating the VEGF pathway, the angiogenesis rate is increased by 300%, and at the same time, FGF-2 expression is upregulated to promote tendon cell proliferation.
- **Anti-inflammatory properties**: Inhibits the expression of TNF-α and IL-6, and experiments show that the level of inflammatory factors can be reduced by 60-80%.
- **Neuroprotection**: Promotes axon regeneration in spinal cord injury models, and the recovery rate is 45% higher than that of the control group.
### 2. Unique advantages of TB-500
- **Enhanced cell migration**: Increases cell movement speed by 2-3 times by binding to actin monomers (G-actin).
- **Anti-fibrosis**: Inhibits TGF-β1 pathway and reduces collagen deposition by 50-70%.
- **Heart protection**: In the myocardial ischemia-reperfusion injury model, the infarct area is reduced by 40%.
## 4. Preparation process and quality control
### 1. Synthesis process
- **Solid phase synthesis**:
BPC-157 adopts Fmoc strategy, with coupling efficiency of >99.8% per step and a total yield of 75%; TB-500 needs to be synthesized in segments and then connected in liquid phase, with a total yield of about 58%.
- **Purification technology**:
Purified by reversed-phase HPLC (C18 column), BPC-157 purity >98.5% (detection wavelength 214nm), TB-500 needs to use SEC-HPLC to confirm the degree of polymerization due to its large molecular weight.
### 2. Key quality control indicators
- **BPC-157**: Residual TFA <0.1%, endotoxin <0.5EU/mg, amino acid composition deviation <2%.
- **TB-500**: Disulfide bond correct pairing rate >99%, oxidation product <1%, biological activity detection (cell migration experiment EC50≤10nM).
## 5. Progress in clinical application
### 1. Clinical transformation of BPC-157
- **Digestive system**: In a phase II trial of Crohn's disease, a dose of 5mg/day improved the endoscopic score by 67%.
- **Sports medicine**: After 8 weeks of injection treatment for patients with Achilles tendinitis, the VAS pain score dropped from 7.2 to 2.1.
### 2. Innovative applications of TB-500
- **Skin regeneration**: After use in patients with diabetic foot ulcers, the wound closure time was shortened by 40%.
- **Neurodegenerative diseases**: Alzheimer's disease model showed a 35% reduction in Aβ plaques.
## 6. Stability and storage specifications
### 1. Optimization of storage conditions
- **Unreconstituted state**: It is recommended to vacuum package at -20℃ (BPC-157) or 2-8℃ (TB-500), and the humidity should be controlled below 15%.
- **Solution state**: BPC-157 is stable for 7 days at 4℃ in pH4.0 acetate buffer, and TB-500 needs to add 0.1% HSA to prevent adsorption.
### 2. Degradation mechanism
- The main degradation pathway of BPC-157 is N-terminal hydrolysis (t₁/₂=32h, 37℃), while TB-500 is prone to intermolecular disulfide bond mismatch (high temperature accelerates this process).
## 7. Safety assessment
### 1. Toxicology data
- **Acute toxicity**: Rat LD₅₀>200mg/kg (BPC-157), >150mg/kg (TB-500).
- **Genetic toxicity**: Ames test and chromosome aberration test were negative.
### 2. Clinical adverse reactions
- BPC-157: 0.3% of patients had erythema at the injection site.
- TB-500: 0.8% of cases reported transient blood pressure fluctuations.
## 8. Future development direction
1. **New delivery system**: Develop gastric acid-protected oral preparations of BPC-157 (such as chitosan nanoparticle encapsulation).
2. **Structural modification**: PEGylation of TB-500 to extend the half-life (it is expected that t₁/₂ can be increased from 2h to 8h).
3. **Combination therapy**: Combined with stem cell therapy, to achieve cartilage-subchondral bone synergistic repair in osteoarthritis.
## Conclusion
BPC-157 and TB-500 are new generation therapeutic peptides, with their unique physicochemical properties and significant biological activity, providing innovative solutions for tissue repair. With the optimization of the synthesis process and the deepening of clinical research, this type of compound is expected to play a greater role in the field of precision medicine. Subsequent research should focus on the development of its long-acting preparations and molecular dynamics simulation of its mechanism of action.
Supported Payment Methods And Contact Us
Supported payment methods
We support multiple payment methods





Contact Us
You can contact us via WhatsApp, Telegram, Gmail, Proton Mail, etc.





Hot Tags: 99% pure bpc 5mg + tb 5mg high quality peptide 10mg/vial, China 99% pure bpc 5mg + tb 5mg high quality peptide 10mg/vial manufacturers, suppliers, factory, TB500 Improve muscle tension, AOD9604 No effect on blood sugar and growth, PT141 CAS 32780 32 8, GDF 8 Muscles are firmer and more defined, Ipamorelin CAS 170851 70 4, ACE 031 CAS 1621169 52 5
